| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/2011 | US20110288064 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 11/24/2011 | US20110288063 Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors |
| 11/24/2011 | US20110288062 Biodegradable polymer system |
| 11/24/2011 | US20110288061 Triterpenoid derivatives, benzenoid derivatives and pharmaceutical compositions containing the same |
| 11/24/2011 | US20110288060 apparatus and process for producing crystals |
| 11/24/2011 | US20110288059 Neuroactive steroid compositions and methods of use therefor |
| 11/24/2011 | US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis |
| 11/24/2011 | US20110288057 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 11/24/2011 | US20110288056 Once daily formulations of tetracyclines |
| 11/24/2011 | US20110288055 Mitoquinone derivatives used as mitochondrially targeted antioxidants |
| 11/24/2011 | US20110288054 Compounds for the treatment of inflammatory disorders |
| 11/24/2011 | US20110288053 Antiviral phosphonate analogs |
| 11/24/2011 | US20110288052 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 11/24/2011 | US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 11/24/2011 | US20110288050 Protein phosphatase inhibitor |
| 11/24/2011 | US20110288049 Compositions, Systems, and/or Methods Involving Chlorine Dioxide ("ClO2") |
| 11/24/2011 | US20110288048 Promoter for hard tissue formation |
| 11/24/2011 | US20110288047 Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations |
| 11/24/2011 | US20110288046 Analysis of sulfated polysacchrides |
| 11/24/2011 | US20110288045 Wet granulation of tenofovir, emtricitabine and efavirenz |
| 11/24/2011 | US20110288044 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 11/24/2011 | US20110288043 Maintenance of platelet inhibition during antiplatelet therapy |
| 11/24/2011 | US20110288042 Stable highly pure azacitidine and preparation methods therefor |
| 11/24/2011 | US20110288041 Antibacterial aminoglycoside analogs |
| 11/24/2011 | US20110288040 Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
| 11/24/2011 | US20110288039 Topical Ectoparasiticide Composition |
| 11/24/2011 | US20110288038 Hesperidin-containing composition |
| 11/24/2011 | US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System |
| 11/24/2011 | US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 11/24/2011 | US20110288033 Disulfide Compounds for Phototherapy |
| 11/24/2011 | US20110288032 Enzastaurin for the treatment of cancer |
| 11/24/2011 | US20110288022 Treatment of depressive disorders |
| 11/24/2011 | US20110288020 Use of VEGF and homologues to treat neuron disorders |
| 11/24/2011 | US20110288014 Methods and compositions for diabetes treatment and prevention |
| 11/24/2011 | US20110288012 Nutrition composition |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110287535 Histone Deacetylase Inhibitors |
| 11/24/2011 | US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT |
| 11/24/2011 | US20110287116 Use of jasmonates for treating heart failure and related cardiac disorders |
| 11/24/2011 | US20110287114 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition |
| 11/24/2011 | US20110287112 Prostate cancer progression inhibitor and progression inhibition method |
| 11/24/2011 | US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 11/24/2011 | US20110287110 Combination cancer treatment |
| 11/24/2011 | US20110287104 Process for the production of an n-butyric acid compound in micro encapsulated form, for animal or human consumption |
| 11/24/2011 | US20110287103 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287101 Rapid release mini-tablets provide analgesia in laboratory animals |
| 11/24/2011 | US20110287100 Galenic Formulations of Organic Compounds |
| 11/24/2011 | US20110287099 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287097 Pharmaceutical compositions comprising ropinirole |
| 11/24/2011 | US20110287096 Modified gastroretentive drug delivery system for amine drugs |
| 11/24/2011 | US20110287095 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| 11/24/2011 | US20110287094 Specific time-delayed burst profile delivery system |
| 11/24/2011 | US20110287093 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| 11/24/2011 | US20110287092 Compositions comprising decitabine and tetrahydrouridine and uses thereof |
| 11/24/2011 | US20110287091 Chronotherapeutic pharmaceutical composition |
| 11/24/2011 | US20110287090 Compositions and Methods for Inhibiting Expression of a Mutant Gene |
| 11/24/2011 | US20110287088 Modulation of olfml-3 mediated angiogenesis |
| 11/24/2011 | US20110287085 Liposomal curcumin for treatment of cancer |
| 11/24/2011 | US20110287084 Method for reducing body fat and increasing lean body mass by reducing stearoyl-coa desaturase 1 activity |
| 11/24/2011 | US20110287083 Bioabsorbable Composition and Coatings Including Same |
| 11/24/2011 | US20110287080 Coating ii |
| 11/24/2011 | US20110287074 Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same |
| 11/24/2011 | US20110287072 Prebiotic formulations and methods of use |
| 11/24/2011 | US20110287069 Solid oral formulations of a pyridopyrimidinone |
| 11/24/2011 | US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof |
| 11/24/2011 | US20110287066 Nanoporous Foamed Active Compound-Containing Preparations Based On Pharmaceutically Acceptable Thermoplastically Workable Polymers |
| 11/24/2011 | US20110287065 Nanoparticulate cinacalcet compositions |
| 11/24/2011 | US20110287064 Antibiotic coating |
| 11/24/2011 | US20110287045 Enhanced immune response against infections |
| 11/24/2011 | US20110287038 Method for treating solid tumors |
| 11/24/2011 | US20110287034 Therapeutic and diagnostic methods relating to cancer stem cells |
| 11/24/2011 | US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels |
| 11/24/2011 | US20110287026 Sirt4 and uses thereof |
| 11/24/2011 | US20110287025 Combination therapy and method for assessing resistance to treatment |
| 11/24/2011 | US20110287010 Diagnostic methods and markers |
| 11/24/2011 | US20110287008 Inhibition of emmprin to treat multiple sclerosis |
| 11/24/2011 | US20110287004 Mg53 compositions and methods of use |
| 11/24/2011 | US20110286998 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors |
| 11/24/2011 | US20110286997 Genetic Alterations on Chromosome 16 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes |
| 11/24/2011 | US20110286995 Drug Therapy for Celiac Sprue |
| 11/24/2011 | US20110286993 Use of hsp70 as a regulator of enzymatic activity |
| 11/24/2011 | US20110286982 Glucagon analogues |
| 11/24/2011 | US20110286981 Glucagon analogues |
| 11/24/2011 | US20110286979 CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA) |
| 11/24/2011 | US20110286965 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 11/24/2011 | US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 11/24/2011 | US20110286962 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 11/24/2011 | US20110286961 Hepatitis C Virus Inhibitors |
| 11/24/2011 | US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use |
| 11/24/2011 | US20110286958 Hpma polymer platinum chelates |
| 11/24/2011 | US20110286957 Multiblock copolymers |
| 11/24/2011 | US20110286956 Novel multi-arm polyethylene glycol, preparation method and uses thereof |
| 11/24/2011 | US20110286951 Transfer resistant cosmetic compositions having a unique texture and feel containing at least two polar modified polymers |
| 11/24/2011 | US20110286950 Cosmetic compositions of varying viscoelasticity |
| 11/24/2011 | US20110286945 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
| 11/24/2011 | US20110286944 Methods and compositions for safe and effective treatment of erythema |
| 11/24/2011 | US20110286942 Topical Composition Comprising a Chaotrope |
| 11/24/2011 | US20110286937 Synthetic glycolipid-containing liposome |
| 11/24/2011 | US20110286930 Methods of identifying modulators of the pp2a b56 beta regulatory subunit |
| 11/24/2011 | US20110286927 ATF4 Inhibitors and Their Use for Neural Protection, Repair, Regeneration, and Plasticity |